Company Profile
Founded 2003Beijing, China
Beijing Konruns Pharmaceutical develops, produces, and sells pharmaceuticals in China and globally. The company offers agkistrodon halys hemocoagulase under Suling trade name. It is also involved in the development of drug candidates, including ZY5301 that is in phase 3 clinical trials for the treatment of chronic pelvic pain in sequelae of pelvic inflammatory disease KC1036, which is in phase 2 clinical trial for the treatment of solid tumors. Founded in 2003, the company is headquartered in Beijing, China.